Cytarabine 68083-0337-01
- Manufacturer
- Gland Pharma Limited
- Dosage Form
- Injection, Solution
- Route
- Intrathecal, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- December 23, 2019
- Listing Expires
- December 31, 2026
- Application
- ANDA211938
Need to source Cytarabine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Cytarabine | 100 mg/mL |
Drug Class
Nucleoside Metabolic Inhibitor [EPC]Nucleic Acid Synthesis Inhibitors [MoA]Nucleoside Metabolic Inhibitor [EPC]
Selected Package
68083-0337-01Selected1 VIAL, SINGLE-DOSE in 1 CARTON (68083-337-01) / 20 mL in 1 VIAL, SINGLE-DOSE